Dave Singh

46PUBLICATIONS
105CO-AUTHORS
Decision makingInnate immunityCharacterisation of biological macromoleculesAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trials.

|May 05, 2026
Safety and antimicrobial efficacy of CSL787, a novel nebulized IgG therapy, in patients with bronchiectasis: results from a randomized phase 1 trial.

|Mar 18, 2026
Early clinical pharmacology evaluation of the novel anti-inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions.

Dave Singh, Kate Hanrott, Olof Breuer

|Dec 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial.

Dave Singh, Chaim M Brickman, Peter Lloyd

|Oct 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.

Seblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan

|Aug 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.

Anna Lundahl, Rod Hughes, Joachim Almquist

Pageof 8

Frequent Collaborators

6 joint publications

David M G Halpin

4 joint publications

MeiLan K Han

3 joint publications

Alberto Papi

3 joint publications

Peter Daley-Yates